View Older Stories View More Recent Stories

Nov 8, 2019 08:53AM Iovanace Biotherapeutics (IOVA) PT Raised to $33 at Chardan Capital Markets
Nov 5, 2019 04:04PM UPDATE: Chardan Capital Markets Starts Rocket Pharmaceuticals (RCKT) at Buy, Sees Over 100% Upside
Nov 5, 2019 09:27AM Krystal Biotech (KRYS) PT Raised to $90 at Chardan Capital Markets
Nov 1, 2019 09:10AM Scienjoy To Become A Public Company Via Business Combination With Wealthbridge
Nov 1, 2019 08:13AM Dicerna Pharmaceuticals (DRNA) PT Increases to $20 at Chardan on Cash Infusion
Oct 28, 2019 10:53AM Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.
Oct 28, 2019 10:25AM Chardan Capital Markets Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
Oct 24, 2019 07:15PM Greenland Acquisition Corporation and Zhongchai Holding (Hong Kong) Limited Announce Closing of Business Combination
Oct 23, 2019 04:40PM UPDATE: Chardan Capital Markets Starts PDS Biotechnology Corp (PDSB) at Buy
Oct 23, 2019 01:55PM Form 8-K Chardan Healthcare Acqui For: Oct 23
Oct 23, 2019 01:53PM Form DEFA14A Chardan Healthcare Acqui
Oct 23, 2019 01:23PM Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.
Oct 23, 2019 11:43AM Provention Bio Inc. (PRVB) PT Lowered to $18.50 at Chardan Capital Markets
Oct 22, 2019 08:38AM PlacementTracker Publishes Q3 2019 PIPE and Private Placement Markets League Tables
Oct 22, 2019 06:01AM Arrowhead Research (ARWR) PT Raised to $45 at Chardan Capital Markets After R&D Day
Oct 21, 2019 10:16AM Form 8-K Chardan Healthcare Acqui For: Oct 21
Oct 18, 2019 08:20AM ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 16, 2019 04:06PM Form 10-Q Chardan Healthcare Acqui For: Sep 30
Oct 16, 2019 06:01AM Form 8-K Chardan Healthcare Acqui For: Oct 15
Oct 16, 2019 06:01AM Form DEFA14A Chardan Healthcare Acqui
Oct 16, 2019 05:48AM ProQR (PRQR) Prices 9.09M Share Offering at $5.50/Sh
Oct 15, 2019 11:17PM ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
Oct 15, 2019 04:48PM Form 8-K Chardan Healthcare Acqui For: Oct 14
Oct 15, 2019 04:46PM Form DEFA14A Chardan Healthcare Acqui
Oct 15, 2019 09:30AM Kodiak Sciences Inc. (KOD) PT Raised to $35 at Chardan Capital Markets
Oct 15, 2019 07:20AM Genius Brands (GNUS) Partners with Alibaba (BABA) for Co-Production Deal; PT Lowered to $4.50 at Chardan Capital Markets
Oct 14, 2019 07:31AM Chardan Healthcare Acquisition (CHAC) Announces Amendment to Merger Agreement with BiomX Ltd.
Oct 14, 2019 07:30AM Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.
Oct 11, 2019 05:30PM Form 8-K Chardan Healthcare Acqui For: Oct 11
Oct 11, 2019 05:28PM Form DEFA14A Chardan Healthcare Acqui
Oct 11, 2019 05:25PM Form DEFA14A Chardan Healthcare Acqui
Oct 10, 2019 04:54PM CORRECTING and REPLACING -- Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
Oct 10, 2019 04:54PM CORRECTING and REPLACING -- Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
Oct 10, 2019 04:07PM Chanticleer Holdings (BURG) Announces Merger Agreement with Sonnet BioTherapeutics
Oct 10, 2019 04:05PM Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
Oct 10, 2019 04:05PM Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
Oct 10, 2019 04:05PM Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
Oct 8, 2019 10:06AM American BriVision Appoints Chihliang "Andy" An as New Chief Financial Officer
Oct 8, 2019 10:06AM American BriVision Appoints Chihliang "Andy" An as New Chief Financial Officer
Oct 4, 2019 03:03PM Form DEFA14A Chardan Healthcare Acqui
Oct 4, 2019 03:02PM Form 8-K Chardan Healthcare Acqui For: Oct 03
Oct 4, 2019 11:00AM The Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines Conference
Oct 4, 2019 07:44AM Chardan Capital Markets Downgrades Arbutus Biopharma (ABUS) to Neutral
Oct 3, 2019 04:45PM MeiraGTx to Present at Upcoming Scientific and Investor Conferences
Oct 3, 2019 04:45PM MeiraGTx to Present at Upcoming Scientific and Investor Conferences
Oct 3, 2019 11:17AM Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant
Oct 3, 2019 08:00AM AVROBIO, Inc. to Present at Chardan’s 3rd Annual Genetic Medicines Conference
Oct 2, 2019 09:00AM Arcturus Therapeutics to Present at Three Upcoming Investor Conferences
Oct 2, 2019 07:30AM Solid Biosciences to Participate in the Chardan 3rd Annual Genetic Medicines Conference
Oct 2, 2019 07:00AM Immunovant to Merge with Health Sciences Acquisitions Corporation, Creating New Publicly Listed FcRn-Focused Company
View More Recent Stories View Older Stories